Global Sleep Apnea Implants Market Overview
The Sleep Apnea Implants Market was valued at USD 0.35 billion in 2023. The Sleep Apnea Implants Market industry is projected to grow from USD 0.36 billion in 2024 to USD 0.53 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.30% during the forecast period (2024 - 2032). The increasing prevalence of sleep apnea and technological advancements are the primary market drivers propelling the market's expansion.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Sleep Apnea Implants Market Trends
- Increasing prevalence of obstructive sleep apnea is driving the market growth
Breathing constantly stops and begins during sleep due to obstructive sleep apnea, causing snoring. Usually, when this problem occurs, the airway is blocked during sleep by the throat muscles periodically relaxing. The use of sleep apnea implants is being driven by the rising number of patients who have obstructive sleep apnea and are not responding well to continuous positive airway pressure (CPAP) devices. For example, global estimates based on five or more events/episodes per hour suggest that, between the ages of 30 and 69, there are 936 million persons with mild to severe OSA and 425 million with moderate to severe OSA globally, according to the UptoDate article updated in January 2023. Inspire Therapy, the remedฤ System, and AIRLIFT are a few of the well-known implanted gadgets available. Obesity and body mass index are related. As a result, it is anticipated that a rise in obesity patients will increase OSA instances. For example, by 2030, 586 million women and 434 million men are predicted to be obese, according to the World Obesity Atlas 2022. Obese individuals have lower muscular activity in the upper respiratory tract, which narrows the airway and causes hypoxic and apneic episodes that eventually lead to sleep apnea. Because of this, a rise in obesity is anticipated to worsen OSA complications and increase the need for sleep apnea implants, which will fuel market CAGR over the projected period.
Additionally, the demand for the investigated marker is also expected to increase throughout the projected period as a result of clinical research and development in the field of obstructive sleep apnea. To assess objective changes in cognition and expressive language following implant and therapy with the Inspire Upper Airway Stimulation (UAS) System, for example, Inspire Medical Systems, Inc. conducted clinical research in June 2021. Therefore, it is projected that research proving the effectiveness of various obstructive sleep apnea implants will spur market expansion throughout the projection period.
Additionally, even with its great incidence, sleep apnea is misdiagnosed in many situations. As knowledge of the condition increases and more people seek treatment for sleep-related problems, there is a chance to find and treat patients who were not previously identified, increasing the number of candidates for sleep apnea implants. Sleep apnea is more common in certain demographic groups, including the elderly, people with concurrent conditions like diabetes or cardiovascular disease, and people with anatomical predispositions. Expanding the pool of patients undergoing sleep apnea implants can be achieved by focusing screening and treatment efforts on these high-risk categories. Thus driving the Sleep Apnea Implants market revenue.
Sleep Apnea Implants Market Segment Insights
Sleep Apnea Implants Product Insights
Based on Product, the Sleep Apnea Implants Market segmentation includes phrenic nerve stimulators, hypoglossal neurostimulation devices, flexible tongue retractor systems, bone screw implant systems, and palatal implants. In 2023, the hypoglossal neurostimulation devices segment dominated the market. Obstructive sleep apnea (OSA) patients who don't respond well to traditional medicines like continuous positive airway pressure (CPAP) or a medical procedure are bound to pick these gadgets as their favored course of therapy. One of the primary drivers of OSA is aviation route breakdown during rest, which is prevented by hypoglossal neurostimulation gadgets, which stimulate the hypoglossal nerve.
The palatal implants category is anticipated to be the fastest growing. To lessen airway blockage and strengthen the soft palate, palatal implants are a minimally invasive approach that entails inserting tiny polyester rods into the palate. This strategy has become more popular since it is more successful, has less recovery time, and is less intrusive than other surgical procedures. Palate implants are a rapidly adopting and expanding market as more and more patients and healthcare professionals look for less intrusive treatment choices.
Sleep Apnea Implants Indication Insights
Based on Indication, the Sleep Apnea Implants Market segmentation includes central sleep apnea and obstructive sleep apnea (OSA). In 2023, the obstructive sleep apnea (OSA) category generated the most income. The more normal kind of sleep apnea, known as obstructive sleep apnea, is characterized by frequent upper airway collapses that impede breathing while you rest. There has been a critical requirement for treatment choices, including implants, because of the way that OSA influences a more extensive patient populace and is regularly perceived all the more frequently. The predominance of the section can be attributed to the rising utilization of gadgets, such as upper airway stimulation systems and hypoglossal nerve stimulators, in the treatment of OSA.
The Sleep Apnea Implants’ central sleep apnea segment market is anticipated to grow fastest during the forecast period. A neurological malfunction that causes slowed or halted breathing during sleep, frequently unrelated to airway blockage, is the hallmark of central sleep apnea. Central sleep apnea is a less common type of sleep apnea. Still, advances in implanted devices like phrenic nerve stimulators and adaptive servo-ventilation systems are making progress in treating it. This market is predicted to expand quickly, serving patients with sleep disorders other than OSA, as awareness of central sleep apnea rises and technology advancements continue to enhance treatment choices.
Sleep Apnea Implants End User Insights
Based on End Users, the Sleep Apnea Implants Market segmentation includes hospitals, ambulatory surgical centers, and office-based clinics. The ambulatory surgical center's category leads the market. Modern implants and cutting-edge surgical techniques are provided by ambulatory surgery centers' licensed physicians and healthcare experts, who also safeguard the facility's general market expansion and consumer favor. Additionally, the availability of these surgical techniques and the increasing demand for them in various healthcare settings to improve patient management and care will further fuel the growth of the sleep apnea implant market in the coming years.
The sleep apnea implants market’s hospital segment is anticipated to grow fastest during the projection period. Sleep clinics and centers for sleep disorders are usually located in hospitals and are furnished with diagnostic tools like polysomnography (PSG) and home sleep apnea testing (HSAT). These services make it possible to accurately diagnose sleep apnea, frequently in conjunction with extensive sleep studies carried out in medical facilities.
Figure 1: Sleep Apnea Implants Market, by End User, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Sleep Apnea Implants Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Sleep Apnea Implants market will dominate this market due to factors including the region's growing prevalence of sleep apnea, growing public awareness, and an increase in sleep apnea implant clinical research. For example, the March 2022 PubMed article describes how the researchers' population-based study revealed that 13.1% of Canadian women (1.2 million) and 21.9% of Canadian men (1.8 million) over 45 were at high risk of presenting with OSA and that the risk was 1.2–2 times higher for middle-aged and older men than for women.
Research studies like these feature the significance of utilizing sleep apnea implants, which drive the market development over the conjecture period. Moreover, in August 2021, the College of Arizona supported a clinical report to evaluate the impacts of respiratory strength preparation on blood pressure and cardiovascular well-being in grown-ups who are 50 years old and more established and have been diagnosed to have moderate or severe obstructive sleep apnea.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: SLEEP APNEA IMPLANTS MARKET SHARE BY REGION 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Sleep Apnea Implants market accounts for the second-largest market share. Modern hospitals, sleep centers, and research institutes are among the state-of-the-art healthcare facilities and infrastructure found throughout Europe. Innovative medical technology, such as sleep apnea implants, are developed, adopted, and used with the backing of this infrastructure. Further, the German Sleep Apnea Implants market held the largest market share, and the UK Sleep Apnea Implants market was the fastest-growing market in the European region.
The Asia-Pacific Sleep Apnea Implants Market is expected to grow at the fastest CAGR from 2024 to 2032 and is primarily driven by an aging populace. One factor contributing to the increased prevalence of sleep disorders like apnea is this demographic trend. Further driving market expansion is anticipated to be the region's increasing prevalence of lifestyle illnesses, which are frequently connected to sleep disturbances. In the upcoming years, the Asia-Pacific area may expect a steady increase in demand for innovative treatment alternatives like sleep apnea implants as knowledge and access to healthcare services improve. Moreover, China’s Sleep Apnea Implants market held the largest market share, and the Indian Sleep Apnea Implants market was the fastest-growing market in the Asia-Pacific region.
Sleep Apnea Implants Key Market Players & Competitive Insights
The industry's leading players will keep investing heavily in R&D to expand their product lines, which will propel the Sleep Apnea Implants market's growth. Contractual agreements, mergers and acquisitions, increased investments, collaboration with other companies, and the production of new products are examples of significant market developments. To increase their worldwide reach, market players also take part in a variety of strategic initiatives. In order to survive and expand in a more competitive and dynamic market, the Sleep Apnea Implants industry must offer reasonably priced products and services.
One of the main strategies manufacturers use in the worldwide Sleep Apnea Implants market is local manufacturing, which expands the market sector and helps customers by lowering operating costs. Some of the biggest medical benefits in recent years have come from the Sleep Apnea Implants sector. Major players in the Sleep Apnea Implants market, including Inspire Medical Systems, Respicardia, Inc., Medtronic Plc, LinguaFlex LLC, Siesta Medical, Inc., Pillar Palatal LLC / The Snoring Center, Nyxoah SA, LivaNova/ImThera, and others, are attempting to increase market demand by investing in research and development operations.
The goal of Inspire Medical Systems Inc. (Inspire Medical) is to create medical technology solutions for people suffering from obstructive sleep apnea (OSA). A neurostimulation method is available from iT to treat moderate to severe OSA. Among the applications on its platform are the Inspired Therapy System, Inspired Physician Programmer, and Inspired Cloud. Additionally, Inspire Medical creates products that track a patient's respiration and subtly stimulate the hypoglossal nerve to keep the airway open. The business takes part in a number of clinical studies for goods in the relevant industry. The FDA approved Inspire Sleep, Inc.'s Inspire 2 implanted top airway stimulation (UAIS) device in March 2023 for the treatment of obstructive sleep apnea (OSA). The tongue receives electric impulses from the Inspire 2, a tiny, wireless gadget implanted in the chest, to prevent it from collapsing during sleep.
Medtronic Plc (Medtronic), originally Medtronic Inc., is a clinical innovation organization that plans, creates, produces, and markets clinical gadgets and arrangements. It offers items for the treatment of heart valve problems, cardiovascular failure, illnesses of the coronary supply route, aortic, fringe vascular, venous renal, and neurological infections, spine and outer muscle issues, and sicknesses of the ear, nose, and throat. Additionally, it offers biologic solutions to the dentistry and orthopedic industries. Hospitals, clinics, institutions, including government healthcare programs, wholesalers, and group purchasing groups are among the customers it serves with its items.
Key Companies in the Sleep Apnea Implants market include
Sleep Apnea Implants Industry Developments
January 2023: NHS physicians are now treating patients with sleeping difficulties using a ground-breaking implant that promotes better sleep. People with sleep apnea have a treatment where a tiny device is implanted in their chest to stop them from stopping and beginning their breathing hundreds of times while they are asleep. In London, the Guy's and St. Thomas' (GSTT) Health Trust is the first NHS provider to use the gadget.
August 2022: StimAire Australia Pty Ltd. funded a clinical trial to assess the impact of using the StimAire Model S system on the Apnea-Hypopnea Index (AHI). By stimulating the hypoglossal nerve, the StimAire Model S aims to cure obstructive sleep apnea (OSA). The system includes a respiration sensor and a separate neurostimulator. Participants with moderate to severe obstructive sleep apnea will utilize the system.
Sleep Apnea Implants Market Segmentation
Sleep Apnea Implants Product Outlook
- Phrenic Nerve Stimulator
- Hypoglossal Neurostimulation Devices
- Flexible Tongue Retractor System
- Bone Screw Implant System
- Palatal Implants
Sleep Apnea Implants Indication Outlook
- Central Sleep Apnea
- Obstructive Sleep Apnea (OSA)
Sleep Apnea Implants End User Outlook
- Hospitals
- Ambulatory Surgical Centers
- Office Based Clinics
Sleep Apnea Implants Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
| Report Attribute/Metric |
Details |
| Market Size 2023 |
USD 0.35 Billion |
| Market Size 2024 |
USD 0.36 Billion |
| Market Size 2032 |
USD 0.53 Billion |
| Compound Annual Growth Rate (CAGR) |
5.30% (2024-2032) |
| Base Year |
2023 |
| Market Forecast Period |
2024-2032 |
| Historical Data |
2019-2022 |
| Market Forecast Units |
Value (USD Billion) |
| Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
Product, Indication, End User, and Region |
| Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered |
The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled |
Inspire Medical Systems, Respicardia, Inc., Medtronic Plc, LinguaFlex LLC, Siesta Medical, Inc., Pillar Palatal LLC / The Snoring Center, Nyxoah SA, LivaNova/ImThera |
| Key Market Opportunities |
ยทย ย ย ย ย ย Increased investment in healthcare expands the capabilities to identify and treat sleep apnea effectively and the integration of telemedicine and remote monitoring. |
| Key Market Dynamics |
ยทย ย ย ย ย ย Increasing prevalence of sleep apnea and technological advancements |
Frequently Asked Questions (FAQ) :
The Sleep Apnea Implants Market size was valued at USD 0.35 Billion in 2023.
The global market is projected to grow at a CAGR of 5.30% during the forecast period, 2024-2032.
North America had the largest share of the global market
The key players in the market are Inspire Medical Systems, Respicardia, Inc., Medtronic Plc, LinguaFlex LLC, Siesta Medical, Inc., Pillar Palatal LLC / The Snoring Center, Nyxoah SA, LivaNova/ImThera.
The Hypoglossal Neurostimulation Devices category dominated the market in 2023.
Obstructive sleep apnea (OSA) has the largest share of the global market.
